In this model of trauma-induced coagulopathy and organ failure, ADAMTS-13 given as an adjunct therapy to resuscitation resulted in earlier shock reversal, improved platelet-driven coagulation as assessed by ROTEM, decreased endothelial damage, and partially reduced organ inflammation. Here, ADAMTS13 is linked to blood coagulation disease.